High-risk R/R LBCL

Clinical trials for High-risk R/R LBCL explained in plain language.

Never miss a new study

Get alerted when new High-risk R/R LBCL trials appear

Sign up with your email to follow new studies for High-risk R/R LBCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Double-Barreled attack: CAR-T plus stem cell transplant takes on aggressive lymphoma

Disease control Recruiting now

This study tests a powerful two-step approach for people with a fast-growing type of lymphoma that has not responded to standard treatments. First, patients receive a CAR-T cell therapy (engineered immune cells) followed by a stem cell transplant with high-dose chemotherapy. The …

Matched conditions: HIGH-RISK R/R LBCL

Phase 2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control

Last updated Jun 27, 2026 12:32 UTC

High-risk R/R LBCL

Get alerted when new High-risk R/R LBCL trials appear

Double-Barreled attack: CAR-T plus stem cell transplant takes on aggressive lymphoma